{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:13:21Z","timestamp":1794694401953,"version":"4.9.1"},"reference-count":229,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41584-021-00625-y","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T17:03:54Z","timestamp":1623344634000},"page":"387-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":336,"title":["Ankylosing spondylitis: an autoimmune or autoinflammatory disease?"],"prefix":"10.1038","volume":"17","author":[{"given":"Daniele","family":"Mauro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0518-8386","authenticated-orcid":false,"given":"Ranjeny","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Guggino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Lories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0538-8211","authenticated-orcid":false,"given":"Matthew A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-1264","authenticated-orcid":false,"given":"Francesco","family":"Ciccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"625_CR1","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1038\/nrdp.2015.13","volume":"1","author":"J Sieper","year":"2015","unstructured":"Sieper, J., Braun, J., Dougados, M. & Baeten, D. Axial spondyloarthritis. Nat. Rev. Dis. Prim. 1, 15013 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"625_CR2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41584-018-0044-2","volume":"14","author":"LS Taams","year":"2018","unstructured":"Taams, L. S., Steel, K. J. A., Srenathan, U., Burns, L. A. & Kirkham, B. W. IL-17 in the immunopathogenesis of spondyloarthritis. Nat. Rev. Rheumatol. 14, 453\u2013466 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"625_CR3","doi-asserted-by":"crossref","first-page":"102421","DOI":"10.1016\/j.jaut.2020.102421","volume":"109","author":"J Krainer","year":"2020","unstructured":"Krainer, J., Siebenhandl, S. & Weinh\u00e4usel, A. Systemic autoinflammatory diseases. J. Autoimmun. 109, 102421 (2020).","journal-title":"J. Autoimmun."},{"key":"625_CR4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle, D. & McDermott, M. F. A proposed classification of the immunological diseases. PLoS Med. 3, e297 (2006).","journal-title":"PLoS Med."},{"key":"625_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"L Wang","year":"2015","unstructured":"Wang, L., Wang, F.-S. & Gershwin, M. E. Human autoimmune diseases: a comprehensive update. J. Intern. Med. 278, 369\u2013395 (2015).","journal-title":"J. Intern. Med."},{"key":"625_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/BOR.0b013e3283534df4","volume":"24","author":"C Ambarus","year":"2012","unstructured":"Ambarus, C., Yeremenko, N., Tak, P. P. & Baeten, D. Pathogenesis of spondyloarthritis. Curr. Opin. Rheumatol. 24, 351\u2013358 (2012).","journal-title":"Curr. Opin. Rheumatol."},{"key":"625_CR7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.autrev.2018.04.002","volume":"17","author":"E Generali","year":"2018","unstructured":"Generali, E., Bose, T., Selmi, C., Voncken, J. W. & Damoiseaux, J. G. M. C. Nature versus nurture in the spectrum of rheumatic diseases: classification of spondyloarthritis as autoimmune or autoinflammatory. Autoimmun. Rev. 17, 935\u2013941 (2018).","journal-title":"Autoimmun. Rev."},{"key":"625_CR8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.berh.2018.09.005","volume":"31","author":"MA Brown","year":"2017","unstructured":"Brown, M. A. & Wordsworth, B. P. Genetics in ankylosing spondylitis \u2013 current state of the art and translation into clinical outcomes. Best Pract. Res. Clin. Rheumatol. 31, 763\u2013776 (2017).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"625_CR9","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun, J. & Sieper, J. Ankylosing spondylitis. Lancet 369, 1379\u20131390 (2007).","journal-title":"Lancet"},{"key":"625_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11926-016-0612-x","volume":"18","author":"TJ Kenna","year":"2016","unstructured":"Kenna, T. J., Hanson, A., Costello, M.-E. & Brown, M. A. Functional genomics and its bench-to-bedside translation pertaining to the identified susceptibility alleles and loci in ankylosing spondylitis. Curr. Rheumatol. Rep. 18, 63 (2016).","journal-title":"Curr. Rheumatol. Rep."},{"key":"625_CR11","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/art.23389","volume":"58","author":"P Rahman","year":"2008","unstructured":"Rahman, P. et al. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum. 58, 1020\u20131025 (2008).","journal-title":"Arthritis Rheum."},{"key":"625_CR12","doi-asserted-by":"crossref","first-page":"O48","DOI":"10.1186\/1546-0096-13-S1-O48","volume":"13","author":"P Galozzi","year":"2015","unstructured":"Galozzi, P. et al. Altered cytokine pattern and inflammatory pathways in monogenic and complex autoinflammatory diseases [abstract]. Pediatr. Rheumatol. 13, O48 (2015).","journal-title":"Pediatr. Rheumatol."},{"key":"625_CR13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ni.3579","volume":"18","author":"R Pfeifle","year":"2017","unstructured":"Pfeifle, R. et al. Regulation of autoantibody activity by the IL-23\u2013TH17 axis determines the onset of autoimmune disease. Nat. Immunol. 18, 104\u2013113 (2017).","journal-title":"Nat. Immunol."},{"key":"625_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2006.05.017","volume":"25","author":"HH Uhlig","year":"2006","unstructured":"Uhlig, H. H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309\u2013318 (2006).","journal-title":"Immunity"},{"key":"625_CR15","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten, D. et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382, 1705\u20131713 (2013).","journal-title":"Lancet"},{"key":"625_CR16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/annrheumdis-2012-202646","volume":"73","author":"IB McInnes","year":"2014","unstructured":"McInnes, I. B. et al. Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial. Ann. Rheum. Dis. 73, 349\u2013356 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010650","volume":"6","author":"P H\u00f8jgaard","year":"2016","unstructured":"H\u00f8jgaard, P. et al. Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: protocol for a prospective, exploratory cohort study. BMJ Open 6, e010650 (2016).","journal-title":"BMJ Open"},{"key":"625_CR18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"PJ Mease","year":"2017","unstructured":"Mease, P. J. et al. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. Ann. Rheum. Dis. 76, 79\u201387 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber, W. et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61, 1693\u20131700 (2012).","journal-title":"Gut"},{"key":"625_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2468-1253(18)30233-4","volume":"3","author":"BG Feagan","year":"2018","unstructured":"Feagan, B. G. et al. Risankizumab in patients with moderate to severe Crohn\u2019s disease: an open-label extension study. Lancet Gastroenterol. Hepatol. 3, 671\u2013680 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"625_CR21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","volume":"77","author":"D Baeten","year":"2018","unstructured":"Baeten, D. et al. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: Results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Ann. Rheum. Dis. 77, 1295\u20131302 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"Evans, D. M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43, 761\u2013767 (2011).","journal-title":"Nat. Genet."},{"key":"625_CR23","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.3389\/fimmu.2018.03132","volume":"9","author":"M Vecellio","year":"2019","unstructured":"Vecellio, M., Cohen, C. J., Roberts, A. R., Wordsworth, P. B. & Kenna, T. J. RUNX3 and T-bet in immunopathogenesis of ankylosing spondylitis \u2014 novel targets for therapy? Front. Immunol. 9, 3132 (2019).","journal-title":"Front. Immunol."},{"key":"625_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.38291","volume":"66","author":"JA Smith","year":"2014","unstructured":"Smith, J. A. & Colbert, R. A. Review: The interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond. Arthritis Rheumatol. 66, 231\u2013241 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR25","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1172\/JCI126567","volume":"130","author":"E Gracey","year":"2020","unstructured":"Gracey, E. et al. TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis. J. Clin. Invest. 130, 1863\u20131878 (2020).","journal-title":"J. Clin. Invest."},{"key":"625_CR26","doi-asserted-by":"crossref","first-page":"363ra149","DOI":"10.1126\/scitranslmed.aag1974","volume":"8","author":"CA Dendrou","year":"2016","unstructured":"Dendrou, C. A. et al. Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity. Sci. Transl. Med. 8, 363ra149 (2016).","journal-title":"Sci. Transl. Med."},{"key":"625_CR27","first-page":"368","volume":"34","author":"T Snelgrove","year":"2007","unstructured":"Snelgrove, T. et al. Association of Toll-like receptor 4 variants and ankylosing spondylitis: a case-control study. J. Rheumatol. 34, 368\u2013370 (2007).","journal-title":"J. Rheumatol."},{"key":"625_CR28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3899\/jrheum.100469","volume":"38","author":"S Assassi","year":"2011","unstructured":"Assassi, S. et al. Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of Toll-like receptor 4 and 5. J. Rheumatol. 38, 87\u201398 (2011).","journal-title":"J. Rheumatol."},{"key":"625_CR29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","volume":"76","author":"F Ciccia","year":"2017","unstructured":"Ciccia, F. et al. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann. Rheum. Dis. 76, 1123\u20131132 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR30","volume":"15","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Genome-wide association study in Turkish and Iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis. PLoS Genet. 15, e1008038 (2019).","journal-title":"PLoS Genet."},{"key":"625_CR31","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/ar4154","volume":"15","author":"S Akar","year":"2013","unstructured":"Akar, S. et al. High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection. Arthritis Res. Ther. 15, R21 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"625_CR32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10067-008-0980-3","volume":"28","author":"T Ka\u015fifo\u011flu","year":"2009","unstructured":"Ka\u015fifo\u011flu, T., \u00c7ali\u015fir, C., Cansu, D. \u00dc. & Korkmaz, C. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin. Rheumatol. 28, 41\u201346 (2009).","journal-title":"Clin. Rheumatol."},{"key":"625_CR33","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1002\/art.27683","volume":"62","author":"F Cosan","year":"2010","unstructured":"Cosan, F. et al. Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum. 62, 3232\u20133236 (2010).","journal-title":"Arthritis Rheum."},{"key":"625_CR34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/03009742.2015.1127413","volume":"45","author":"O Varan","year":"2016","unstructured":"Varan, O., Kucuk, H. & Tufan, A. Anakinra for the treatment of familial Mediterranean fever-associated spondyloarthritis. Scand. J. Rheumatol. 45, 252\u2013253 (2016).","journal-title":"Scand. J. Rheumatol."},{"key":"625_CR35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/rheumatology\/kew290","volume":"56","author":"S Georgin-Lavialle","year":"2017","unstructured":"Georgin-Lavialle, S. et al. Spondyloarthritis associated with familial Mediterranean fever: successful treatment with anakinra. Rheumatology 56, 167\u2013169 (2017).","journal-title":"Rheumatology"},{"key":"625_CR36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"International Genetics of Ankylosing Spondylitis Consortium (IGAS)","year":"2013","unstructured":"International Genetics of Ankylosing Spondylitis Consortium (IGAS). et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet. 45, 730\u2013738 (2013).","journal-title":"Nat. Genet."},{"key":"625_CR37","volume":"6","author":"H Chen","year":"2016","unstructured":"Chen, H. et al. ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing. Sci. Rep. 6, 28902 (2016).","journal-title":"Sci. Rep."},{"key":"625_CR38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature13322","volume":"512","author":"L Vande Walle","year":"2014","unstructured":"Vande Walle, L. et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature 512, 69\u201373 (2014).","journal-title":"Nature"},{"key":"625_CR39","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8146","volume":"6","author":"A Cortes","year":"2015","unstructured":"Cortes, A. et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat. Commun. 6, 7146 (2015).","journal-title":"Nat. Commun."},{"key":"625_CR40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5114\/ada.2018.76226","volume":"35","author":"M Stawczyk-Macieja","year":"2018","unstructured":"Stawczyk-Macieja, M. et al. ERAP1 and HLA-C*06 are strongly associated with the risk of psoriasis in the population of northern Poland. Adv. Dermatol. Allergol. 35, 286\u2013292 (2018).","journal-title":"Adv. Dermatol. Allergol."},{"key":"625_CR41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-39113-5","volume":"9","author":"S Burillo-Sanz","year":"2019","unstructured":"Burillo-Sanz, S. et al. Beh\u00e7et\u2019s disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes. Sci. Rep. 9, 2777 (2019).","journal-title":"Sci. Rep."},{"key":"625_CR42","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1093\/hmg\/ddu307","volume":"23","author":"JJW Kuiper","year":"2014","unstructured":"Kuiper, J. J. W. et al. A genome-wide association study identifies a functional ERAP2 haplotype associated with birdshot chorioretinopathy. Hum. Mol. Genet. 23, 6081\u20136087 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"625_CR43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molimm.2016.08.005","volume":"77","author":"JA L\u00f3pez de Castro","year":"2016","unstructured":"L\u00f3pez de Castro, J. A. et al. Molecular and pathogenic effects of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in MHC-I-associated inflammatory disorders: towards a unifying view. Mol. Immunol. 77, 193\u2013204 (2016).","journal-title":"Mol. Immunol."},{"key":"625_CR44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/08916934.2013.819855","volume":"46","author":"SS Seregin","year":"2013","unstructured":"Seregin, S. S. et al. Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens. Autoimmunity 46, 497\u2013508 (2013).","journal-title":"Autoimmunity"},{"key":"625_CR45","first-page":"4333","volume":"27","author":"JJW Kuiper","year":"2018","unstructured":"Kuiper, J. J. W. et al. Functionally distinct ERAP1 and ERAP2 are a hallmark of HLA-A29-(birdshot) uveitis. Hum. Mol. Genet. 27, 4333\u20134343 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"625_CR46","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.3389\/fimmu.2018.02933","volume":"9","author":"F Costantino","year":"2018","unstructured":"Costantino, F., Breban, M. & Garchon, H.-J. Genetics and functional genomics of spondyloarthritis. Front. Immunol. 9, 2933 (2018).","journal-title":"Front. Immunol."},{"key":"625_CR47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"KK-H Farh","year":"2015","unstructured":"Farh, K. K.-H. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337\u2013343 (2015).","journal-title":"Nature"},{"key":"625_CR48","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/annrheumdis-2015-208677","volume":"76","author":"MC Lau","year":"2017","unstructured":"Lau, M. C. et al. Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis. Ann. Rheum. Dis. 76, 261\u2013269 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","volume":"13","author":"M Bombardieri","year":"2017","unstructured":"Bombardieri, M., Lewis, M. & Pitzalis, C. Ectopic lymphoid neogenesis in rheumatic autoimmune diseases. Nat. Rev. Rheumatol. 13, 141\u2013154 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"625_CR50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.1235","volume":"198","author":"P Demetter","year":"2002","unstructured":"Demetter, P. et al. Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis. J. Pathol. 198, 517\u2013522 (2002).","journal-title":"J. Pathol."},{"key":"625_CR51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/ar4532","volume":"16","author":"AT Masi","year":"2014","unstructured":"Masi, A. T. Might axial myofascial properties and biomechanical mechanisms be relevant to ankylosing spondylitis and axial spondyloarthritis? Arthritis Res. Ther. 16, 107 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"625_CR52","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2018.02668","volume":"9","author":"A Watad","year":"2018","unstructured":"Watad, A. et al. The early phases of ankylosing spondylitis: emerging insights from clinical and basic science. Front. Immunol. 9, 2668 (2018).","journal-title":"Front. Immunol."},{"key":"625_CR53","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.berh.2018.07.011","volume":"31","author":"K Debusschere","year":"2017","unstructured":"Debusschere, K., Cambr\u00e9, I., Gracey, E. & Elewaut, D. Born to run: The paradox of biomechanical force in spondyloarthritis from an evolutionary perspective. Best Pract. Res. Clin. Rheumatol. 31, 887\u2013894 (2017).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"625_CR54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11926-018-0751-3","volume":"20","author":"A Watad","year":"2018","unstructured":"Watad, A., Cuthbert, R. J., Amital, H. & McGonagle, D. Enthesitis: Much more than focal insertion point inflammation. Curr. Rheumatol. Rep. 20, 41 (2018).","journal-title":"Curr. Rheumatol. Rep."},{"key":"625_CR55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00002281-200107000-00003","volume":"13","author":"RJ Fran\u00e7ois","year":"2001","unstructured":"Fran\u00e7ois, R. J., Braun, J. & Khan, M. A. Entheses and enthesitis: a histopathologic review and relevance to spondyloarthritides. Curr. Opin. Rheumatol. 13, 255\u2013264 (2001).","journal-title":"Curr. Opin. Rheumatol."},{"key":"625_CR56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","volume":"13","author":"G Schett","year":"2017","unstructured":"Schett, G. et al. Enthesitis: from pathophysiology to treatment. Nat. Rev. Rheumatol. 13, 731\u2013741 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"625_CR57","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/art.40429","volume":"70","author":"U Weber","year":"2018","unstructured":"Weber, U. et al. Frequency and anatomic distribution of magnetic resonance imaging features in the sacroiliac joints of young athletes: Exploring \u201cbackground noise\u201d toward a data-driven definition of sacroiliitis in early spondyloarthritis. Arthritis Rheumatol. 70, 736\u2013745 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR58","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/rheumatology\/kex491","volume":"57","author":"G Varkas","year":"2018","unstructured":"Varkas, G. et al. Effect of mechanical stress on magnetic resonance imaging of the sacroiliac joints: assessment of military recruits by magnetic resonance imaging study. Rheumatology 57, 508\u2013513 (2018).","journal-title":"Rheumatology"},{"key":"625_CR59","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2020-217095","volume":"79","author":"T Renson","year":"2020","unstructured":"Renson, T. et al. High prevalence of spondyloarthritis-like MRI lesions in postpartum women: a prospective analysis in relation to maternal, child and birth characteristics. Ann. Rheum. Dis. 79, 929\u2013934 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR60","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock, J. P. et al. IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+CD3+CD4\u2212CD8\u2212 entheseal resident T cells. Nat. Med. 18, 1069\u20131076 (2012).","journal-title":"Nat. Med."},{"key":"625_CR61","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/art.40150","volume":"69","author":"RJ Cuthbert","year":"2017","unstructured":"Cuthbert, R. J. et al. Brief report: group 3 innate lymphoid cells in human enthesis. Arthritis Rheumatol. 69, 1816\u20131822 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR62","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2018-214944","volume":"78","author":"C Bridgewood","year":"2019","unstructured":"Bridgewood, C. et al. Identification of myeloid cells in the human enthesis as the main source of local IL-23 production. Ann. Rheum. Dis. 78, 929\u2013933 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR63","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","volume":"73","author":"P Jacques","year":"2014","unstructured":"Jacques, P. et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann. Rheum. Dis. 73, 437\u2013445 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR64","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.23704","volume":"59","author":"MM Ward","year":"2008","unstructured":"Ward, M. M., Reveille, J. D., Learch, T. J., Davis, J. C. & Weisman, M. H. Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis. Arthritis Rheum. 59, 822\u2013832 (2008).","journal-title":"Arthritis Rheum."},{"key":"625_CR65","volume":"1","author":"S Ramiro","year":"2015","unstructured":"Ramiro, S. et al. Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis. RMD Open 1, e000153 (2015).","journal-title":"RMD Open"},{"key":"625_CR66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11914-013-0183-y","volume":"12","author":"R Baum","year":"2014","unstructured":"Baum, R. & Gravallese, E. M. Impact of inflammation on the osteoblast in rheumatic diseases. Curr. Osteoporos. Rep. 12, 9\u201316 (2014).","journal-title":"Curr. Osteoporos. Rep."},{"key":"625_CR67","volume":"9","author":"P Lin","year":"2014","unstructured":"Lin, P. et al. HLA-B27 and human \u03b22-microglobulin affect the gut microbiota of transgenic rats. PLoS ONE 9, e105684 (2014).","journal-title":"PLoS ONE"},{"key":"625_CR68","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/art.38773","volume":"66","author":"LM Rehaume","year":"2014","unstructured":"Rehaume, L. M. et al. ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice. Arthritis Rheumatol. 66, 2780\u20132792 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR69","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/annrheumdis-2018-214381","volume":"78","author":"LM Rehaume","year":"2019","unstructured":"Rehaume, L. M. et al. IL-23 favours outgrowth of spondyloarthritis-associated pathobionts and suppresses host support for homeostatic microbiota. Ann. Rheum. Dis. 78, 494\u2013503 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR70","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.34423","volume":"64","author":"M Ruutu","year":"2012","unstructured":"Ruutu, M. et al. \u03b2-glucan triggers spondylarthritis and Crohn\u2019s disease-like ileitis in SKG mice. Arthritis Rheum. 64, 2211\u20132222 (2012).","journal-title":"Arthritis Rheum."},{"key":"625_CR71","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.4049\/jimmunol.1000848","volume":"185","author":"S Tanaka","year":"2010","unstructured":"Tanaka, S. et al. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function. J. Immunol. 185, 2295\u20132305 (2010).","journal-title":"J. Immunol."},{"key":"625_CR72","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.38967","volume":"67","author":"M-E Costello","year":"2015","unstructured":"Costello, M.-E. et al. Brief report: intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol. 67, 686\u2013691 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR73","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/art.39802","volume":"69","author":"RY Tito","year":"2017","unstructured":"Tito, R. Y. et al. Brief report: dialister as a microbial marker of disease activity in spondyloarthritis. Arthritis Rheumatol. 69, 114\u2013121 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR74","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/annrheumdis-2016-211064","volume":"76","author":"M Breban","year":"2017","unstructured":"Breban, M. et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis. Ann. Rheum. Dis. 76, 1614\u20131622 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR75","volume":"18","author":"C Wen","year":"2017","unstructured":"Wen, C. et al. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. Genome Biol. 18, 142 (2017).","journal-title":"Genome Biol."},{"key":"625_CR76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cca.2019.07.038","volume":"497","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Fecal microbiota in patients with ankylosing spondylitis: correlation with dietary factors and disease activity. Clin. Chim. Acta 497, 189\u2013196 (2019).","journal-title":"Clin. Chim. Acta"},{"key":"625_CR77","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/annrheumdis-2019-215763","volume":"79","author":"J Yin","year":"2020","unstructured":"Yin, J. et al. Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy and the host\u2019s genotype upon microbiome composition. Ann. Rheum. Dis. 79, 132\u2013140 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR78","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.41169","volume":"72","author":"J Manasson","year":"2020","unstructured":"Manasson, J. et al. Interleukin-17 inhibition in spondyloarthritis is associated with subclinical gut microbiome perturbations and a distinctive interleukin-25-driven intestinal inflammation. Arthritis Rheumatol. 72, 645\u2013657 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR79","doi-asserted-by":"crossref","first-page":"102360","DOI":"10.1016\/j.jaut.2019.102360","volume":"107","author":"C Zhou","year":"2019","unstructured":"Zhou, C. et al. Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis. J. Autoimmun. 107, 102360 (2019).","journal-title":"J. Autoimmun."},{"key":"625_CR80","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/art.40917","volume":"71","author":"M Asquith","year":"2019","unstructured":"Asquith, M. et al. HLA alleles associated with risk of ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome. Arthritis Rheumatol. 71, 1642\u20131650 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR81","doi-asserted-by":"crossref","first-page":"eaaf9655","DOI":"10.1126\/scitranslmed.aaf9655","volume":"9","author":"M Viladomiu","year":"2017","unstructured":"Viladomiu, M. et al. IgA-coated E. coli enriched in Crohn\u2019s disease spondyloarthritis promote TH17-dependent inflammation. Sci. Transl. Med. 9, eaaf9655 (2017).","journal-title":"Sci. Transl. Med."},{"key":"625_CR82","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s13075-014-0486-0","volume":"16","author":"ML Stoll","year":"2014","unstructured":"Stoll, M. L. et al. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res. Ther. 16, 486 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"625_CR83","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2017.00476","volume":"8","author":"F Salas-Cuestas","year":"2017","unstructured":"Salas-Cuestas, F. et al. Higher levels of secretory IgA are associated with low disease activity index in patients with reactive arthritis and undifferentiated spondyloarthritis. Front. Immunol. 8, 476 (2017).","journal-title":"Front. Immunol."},{"key":"625_CR84","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/ard.44.11.766","volume":"44","author":"MJ Franssen","year":"1985","unstructured":"Franssen, M. J., van de Putte, L. B. & Gribnau, F. W. IgA serum levels and disease activity in ankylosing spondylitis: a prospective study. Ann. Rheum. Dis. 44, 766\u2013771 (1985).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR85","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/art.39681","volume":"68","author":"MJ Asquith","year":"2016","unstructured":"Asquith, M. J. et al. Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis. Arthritis Rheumatol. 68, 2151\u20132162 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR86","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imm.12896","volume":"154","author":"Q Zhao","year":"2018","unstructured":"Zhao, Q. & Elson, C. O. Adaptive immune education by gut microbiota antigens. Immunology 154, 28\u201337 (2018).","journal-title":"Immunology"},{"key":"625_CR87","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41584-018-0152-z","volume":"15","author":"GJ Silverman","year":"2019","unstructured":"Silverman, G. J. The microbiome in SLE pathogenesis. Nat. Rev. Rheumatol. 15, 72\u201374 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"625_CR88","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4049\/jimmunol.1601519","volume":"198","author":"A Paun","year":"2017","unstructured":"Paun, A., Yau, C. & Danska, J. S. The influence of the microbiome on type 1 diabetes. J. Immunol. 198, 590\u2013595 (2017).","journal-title":"J. Immunol."},{"key":"625_CR89","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39732","volume":"68","author":"A Reinhardt","year":"2016","unstructured":"Reinhardt, A. et al. Interleukin-23-dependent \u03b3\/\u03b4 T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice. Arthritis Rheumatol. 68, 2476\u20132486 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR90","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","volume":"64","author":"T Noordenbos","year":"2012","unstructured":"Noordenbos, T. et al. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum. 64, 99\u2013109 (2012).","journal-title":"Arthritis Rheum."},{"key":"625_CR91","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1136\/annrheumdis-2018-213418","volume":"77","author":"F Rivellese","year":"2018","unstructured":"Rivellese, F. et al. Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production. Ann. Rheum. Dis. 77, 1773\u20131781 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR92","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","volume":"13","author":"H Appel","year":"2011","unstructured":"Appel, H. et al. Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res. Ther. 13, R95 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"625_CR93","volume":"7","author":"AE Price","year":"2012","unstructured":"Price, A. E., Reinhardt, R. L., Liang, H.-E. & Locksley, R. M. Marking and quantifying IL-17A-producing cells in vivo. PLoS ONE 7, e39750 (2012).","journal-title":"PLoS ONE"},{"key":"625_CR94","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1189\/jlb.3HI1215-542R","volume":"100","author":"T Noordenbos","year":"2016","unstructured":"Noordenbos, T. et al. Human mast cells capture, store, and release bioactive, exogenous IL-17A. J. Leukoc. Biol. 100, 453\u2013462 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"625_CR95","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrrheum.2012.205","volume":"9","author":"TJ Kenna","year":"2013","unstructured":"Kenna, T. J. & Brown, M. A. The role of IL-17-secreting mast cells in inflammatory joint disease. Nat. Rev. Rheumatol. 9, 375\u2013379 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"625_CR96","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/annrheumdis-2019-215356","volume":"78","author":"DG McGonagle","year":"2019","unstructured":"McGonagle, D. G., McInnes, I. B., Kirkham, B. W., Sherlock, J. & Moots, R. The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies. Ann. Rheum. Dis. 78, 1167\u20131178 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR97","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3389\/fimmu.2018.00795","volume":"9","author":"N Tamassia","year":"2018","unstructured":"Tamassia, N. et al. A reappraisal on the potential ability of human neutrophils to express and produce IL-17 family members in vitro: failure to reproducibly detect it. Front. Immunol. 9, 795 (2018).","journal-title":"Front. Immunol."},{"key":"625_CR98","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/key331","volume":"58","author":"S Chen","year":"2019","unstructured":"Chen, S. et al. Histologic evidence that mast cells contribute to local tissue inflammation in peripheral spondyloarthritis by regulating interleukin-17A content. Rheumatology 58, 617\u2013627 (2019).","journal-title":"Rheumatology"},{"key":"625_CR99","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-1050-2","volume":"14","author":"JE Paramarta","year":"2016","unstructured":"Paramarta, J. E. et al. A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis. J. Transl. Med. 14, 308 (2016).","journal-title":"J. Transl. Med."},{"key":"625_CR100","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.61.6.534","volume":"61","author":"D McGonagle","year":"2002","unstructured":"McGonagle, D. et al. Histological assessment of the early enthesitis lesion in spondyloarthropathy. Ann. Rheum. Dis. 61, 534\u2013537 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR101","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.59.2.135","volume":"59","author":"M Bollow","year":"2000","unstructured":"Bollow, M. et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis \u2014 cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann. Rheum. Dis. 59, 135\u2013140 (2000).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR102","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun, J. et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 38, 499\u2013505 (1995).","journal-title":"Arthritis Rheum."},{"key":"625_CR103","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/art.23512","volume":"58","author":"JA Smith","year":"2008","unstructured":"Smith, J. A. et al. Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-\u03b3 dysregulation. Arthritis Rheum. 58, 1640\u20131649 (2008).","journal-title":"Arthritis Rheum."},{"key":"625_CR104","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/art.20174","volume":"50","author":"D Baeten","year":"2004","unstructured":"Baeten, D. et al. Association of CD163+macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis Rheum. 50, 1611\u20131623 (2004).","journal-title":"Arthritis Rheum."},{"key":"625_CR105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/rheumatology\/ket323","volume":"53","author":"F Ciccia","year":"2014","unstructured":"Ciccia, F. et al. Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis. Rheumatology 53, 104\u2013113 (2014).","journal-title":"Rheumatology"},{"key":"625_CR106","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20140678","volume":"211","author":"RS Longman","year":"2014","unstructured":"Longman, R. S. et al. CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. 211, 1571\u20131583 (2014).","journal-title":"J. Exp. Med."},{"key":"625_CR107","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11809","volume":"494","author":"GE Diehl","year":"2013","unstructured":"Diehl, G. E. et al. Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX3CR1hi cells. Nature 494, 116\u2013120 (2013).","journal-title":"Nature"},{"key":"625_CR108","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/art.40582","volume":"70","author":"F Ciccia","year":"2018","unstructured":"Ciccia, F. et al. Proinflammatory CX3CR1+CD59+Tumor Necrosis Factor\u2013Like Molecule 1\u2009A+Interleukin-23+monocytes are expanded in patients with ankylosing spondylitis and modulate innate lymphoid cell 3 immune functions. Arthritis Rheumatol. 70, 2003\u20132013 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR109","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.4049\/jimmunol.1201650","volume":"190","author":"K Yaddanapudi","year":"2013","unstructured":"Yaddanapudi, K. et al. Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor. J. Immunol. 190, 2984\u20132993 (2013).","journal-title":"J. Immunol."},{"key":"625_CR110","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/10799900050151012","volume":"20","author":"J Nishihira","year":"2000","unstructured":"Nishihira, J. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J. Interf. Cytokine Res. 20, 751\u2013762 (2000).","journal-title":"J. Interf. Cytokine Res."},{"key":"625_CR111","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/art.40175","volume":"69","author":"V Ranganathan","year":"2017","unstructured":"Ranganathan, V. et al. Macrophage migration inhibitory factor induces inflammation and predicts spinal progression in ankylosing spondylitis. Arthritis Rheumatol. 69, 1796\u20131806 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR112","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1080\/14728222.2016.1251582","volume":"20","author":"J Bloom","year":"2016","unstructured":"Bloom, J., Sun, S. & Al-Abed, Y. MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development. Expert Opin. Ther. Targets 20, 1463\u20131475 (2016).","journal-title":"Expert Opin. Ther. Targets"},{"key":"625_CR113","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits, H. et al. Innate lymphoid cells \u2014 a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145\u2013149 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"625_CR114","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-019-0834-9","volume":"21","author":"D Mauro","year":"2019","unstructured":"Mauro, D., Macaluso, F., Fasano, S., Alessandro, R. & Ciccia, F. ILC3 in axial spondyloarthritis: the gut angle. Curr. Rheumatol. Rep. 21, 37 (2019).","journal-title":"Curr. Rheumatol. Rep."},{"key":"625_CR115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fimmu.2012.00072","volume":"3","author":"K Hoorweg","year":"2012","unstructured":"Hoorweg, K. et al. Functional differences between human NKp44\u2212 and NKp44+ RORC+ innate lymphoid cells. Front. Immunol. 3, 72 (2012).","journal-title":"Front. Immunol."},{"key":"625_CR116","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","volume":"74","author":"F Ciccia","year":"2015","unstructured":"Ciccia, F. et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann. Rheum. Dis. 74, 1739\u20131747 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR117","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1136\/annrheumdis-2016-209749","volume":"75","author":"F Ciccia","year":"2016","unstructured":"Ciccia, F. et al. Clinical efficacy of \u03b14 integrin block with natalizumab in ankylosing spondylitis. Ann. Rheum. Dis. 75, 2053\u20132054 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR118","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3389\/fimmu.2018.01489","volume":"9","author":"C Mortier","year":"2018","unstructured":"Mortier, C., Govindarajan, S., Venken, K. & Elewaut, D. It takes \u2018guts\u2019 to cause joint inflammation: Role of innate-like T cells. Front. Immunol. 9, 1498 (2018).","journal-title":"Front. Immunol."},{"key":"625_CR119","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07911-6","volume":"10","author":"K Venken","year":"2019","unstructured":"Venken, K. et al. ROR\u03b3t inhibition selectively targets IL-17 producing iNKT and \u03b3\u03b4-T cells enriched in spondyloarthritis patients. Nat. Commun. 10, 9 (2019).","journal-title":"Nat. Commun."},{"key":"625_CR120","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","volume":"75","author":"E Gracey","year":"2016","unstructured":"Gracey, E. et al. IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis. Ann. Rheum. Dis. 75, 2124\u20132132 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR121","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/imcb.12021","volume":"96","author":"NA Gherardin","year":"2018","unstructured":"Gherardin, N. A. et al. Human blood MAIT cell subsets defined using MR1 tetramers. Immunol. Cell Biol. 96, 507\u2013525 (2018).","journal-title":"Immunol. Cell Biol."},{"key":"625_CR122","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000821","volume":"4","author":"E Toussirot","year":"2018","unstructured":"Toussirot, E. & Saas, P. MAIT cells: potent major cellular players in the IL-17 pathway of spondyloarthritis? RMD Open 4, e000821 (2018).","journal-title":"RMD Open"},{"key":"625_CR123","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature11605","volume":"491","author":"L Kjer-Nielsen","year":"2012","unstructured":"Kjer-Nielsen, L. et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491, 717\u2013723 (2012).","journal-title":"Nature"},{"key":"625_CR124","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12393-1","volume":"10","author":"H Al-Mossawi","year":"2019","unstructured":"Al-Mossawi, H. et al. Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele. Nat. Commun. 10, 4575 (2019).","journal-title":"Nat. Commun."},{"key":"625_CR125","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3389\/fimmu.2018.01610","volume":"9","author":"\u00c9 Toussirot","year":"2018","unstructured":"Toussirot, \u00c9., Laheurte, C., Gaugler, B., Gabriel, D. & Saas, P. Increased IL-22-and IL-17A-producing mucosal-associated invariant T cells in the peripheral blood of patients with ankylosing spondylitis. Front. Immunol. 9, 1610 (2018).","journal-title":"Front. Immunol."},{"key":"625_CR126","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3899\/jrheum.151133","volume":"43","author":"E Hayashi","year":"2016","unstructured":"Hayashi, E. et al. Involvement of mucosal-associated invariant T cells in ankylosing spondylitis. J. Rheumatol. 43, 1695\u20131703 (2016).","journal-title":"J. Rheumatol."},{"issue":"Suppl. 2","key":"625_CR127","first-page":"862","volume":"78","author":"N Rosine","year":"2019","unstructured":"Rosine, N. et al. FRI0361 Innate versusadaptive IL-17A producing cells in axial spondyloarthritis. [abstract]. Ann. Rheum. Dis. 78 (Suppl. 2), 862\u2013863 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.immuni.2009.06.020","volume":"31","author":"B Martin","year":"2009","unstructured":"Martin, B., Hirota, K., Cua, D. J., Stockinger, B. & Veldhoen, M. Interleukin-17-producing \u03b3\u03b4 T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321\u2013330 (2009).","journal-title":"Immunity"},{"key":"625_CR129","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.33507","volume":"64","author":"TJ Kenna","year":"2012","unstructured":"Kenna, T. J. et al. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive \u03b3\/\u03b4 T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 64, 1420\u20131429 (2012).","journal-title":"Arthritis Rheum."},{"key":"625_CR130","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.24687","volume":"60","author":"Y Ito","year":"2009","unstructured":"Ito, Y. et al. Gamma\/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum. 60, 2294\u20132303 (2009).","journal-title":"Arthritis Rheum."},{"key":"625_CR131","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clim.2017.03.016","volume":"183","author":"AC Chowdhury","year":"2017","unstructured":"Chowdhury, A. C., Chaurasia, S., Mishra, S. K., Aggarwal, A. & Misra, R. IL-17 and IFN-\u03b3 producing NK and \u03b3\u03b4-T cells are preferentially expanded in synovial fluid of patients with reactive arthritis and undifferentiated spondyloarthritis. Clin. Immunol. 183, 207\u2013212 (2017).","journal-title":"Clin. Immunol."},{"key":"625_CR132","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2019-215210","volume":"78","author":"RJ Cuthbert","year":"2019","unstructured":"Cuthbert, R. J. et al. Evidence that tissue resident human enthesis \u03b3\u03b4T-cells can produce IL-17A independently of IL-23R transcript expression. Ann. Rheum. Dis. 78, 1559\u20131565 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR133","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/art.27324","volume":"62","author":"P Jacques","year":"2010","unstructured":"Jacques, P. et al. Invariant natural killer T cells are natural regulators of murine spondylarthritis. Arthritis Rheum. 62, 988\u2013999 (2010).","journal-title":"Arthritis Rheum."},{"key":"625_CR134","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig, T., Henao-Mejia, J., Elinav, E. & Flavell, R. Inflammasomes in health and disease. Nature 481, 278\u2013286 (2012).","journal-title":"Nature"},{"key":"625_CR135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1189\/jlb.1012543","volume":"93","author":"KHG Mills","year":"2013","unstructured":"Mills, K. H. G., Dungan, L. S., Jones, S. A. & Harris, J. The role of inflammasome-derived IL-1 in driving IL-17 responses. J. Leukoc. Biol. 93, 489\u2013497 (2013).","journal-title":"J. Leukoc. Biol."},{"key":"625_CR136","volume":"5","author":"RKW Mailer","year":"2015","unstructured":"Mailer, R. K. W. et al. IL-1\u03b2 promotes Th17 differentiation by inducing alternative splicing of FOXP3. Sci. Rep. 5, 14674 (2015).","journal-title":"Sci. Rep."},{"key":"625_CR137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002404","volume":"3","author":"Y Iwai","year":"2008","unstructured":"Iwai, Y. et al. An IFN-gamma-IL-18 signaling loop accelerates memory CD8+ T cell proliferation. PLoS ONE 3, e2404 (2008).","journal-title":"PLoS ONE"},{"key":"625_CR138","volume":"12","author":"L Zhong","year":"2017","unstructured":"Zhong, L., Song, H., Wang, W., Li, J. & Ma, M. MEFV M694V mutation has a role in susceptibility to ankylosing spondylitis: a meta-analysis. PLoS ONE 12, e0182967 (2017).","journal-title":"PLoS ONE"},{"key":"625_CR139","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/gene.2016.48","volume":"18","author":"Q Xia","year":"2017","unstructured":"Xia, Q. et al. Autophagy-related IRGM genes confer susceptibility to ankylosing spondylitis in a Chinese female population: a case\u2013control study. Genes. Immun. 18, 42\u201347 (2017).","journal-title":"Genes. Immun."},{"key":"625_CR140","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/ard.2004.028837","volume":"64","author":"D Laukens","year":"2005","unstructured":"Laukens, D. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn\u2019s disease. Ann. Rheum. Dis. 64, 930\u2013935 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR141","doi-asserted-by":"publisher","DOI":"10.1002\/art.41644","author":"G Guggino","year":"2021","unstructured":"Guggino, G. et al. Inflammasome activation in ankylosing spondylitis is associated to gut dysbiosis. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.41644 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR142","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/ard.2004.020800","volume":"63","author":"AL Tan","year":"2004","unstructured":"Tan, A. L. et al. Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study. Ann. Rheum. Dis. 63, 1041\u20131045 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR143","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/ard.2004.023176","volume":"64","author":"H Haibel","year":"2005","unstructured":"Haibel, H., Rudwaleit, M., Listing, J. & Sieper, J. Open label trial of anakinra in active ankylosing spondylitis over 24 weeks. Ann. Rheum. Dis. 64, 296\u2013298 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR144","doi-asserted-by":"crossref","first-page":"930509","DOI":"10.1155\/2010\/930509","volume":"2010","author":"T Verfaillie","year":"2010","unstructured":"Verfaillie, T., Salazar, M., Velasco, G. & Agostinis, P. Linking ER stress to autophagy: potential implications for cancer therapy. Int. J. Cell Biol. 2010, 930509 (2010).","journal-title":"Int. J. Cell Biol."},{"key":"625_CR145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrrheum.2016.192","volume":"13","author":"F Navid","year":"2017","unstructured":"Navid, F. & Colbert, R. A. Causes and consequences of endoplasmic reticulum stress in rheumatic disease. Nat. Rev. Rheumatol. 13, 25\u201340 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"625_CR146","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2017.01.007","volume":"176","author":"DJ Wu","year":"2017","unstructured":"Wu, D. J. & Adamopoulos, I. E. Autophagy and autoimmunity. Clin. Immunol. 176, 55\u201362 (2017).","journal-title":"Clin. Immunol."},{"key":"625_CR147","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/infdis\/jiu675","volume":"211","author":"H Saiga","year":"2015","unstructured":"Saiga, H. et al. The recombinant BCG \u0394ureC::hly vaccine targets the AIM2 inflammasome to induce autophagy and inflammation. J. Infect. Dis. 211, 1831\u20131841 (2015).","journal-title":"J. Infect. Dis."},{"key":"625_CR148","volume":"8","author":"Y Yao","year":"2017","unstructured":"Yao, Y. et al. Antigen-specific CD8+ T cell feedback activates NLRP3 inflammasome in antigen-presenting cells through perforin. Nat. Commun. 8, 15402 (2017).","journal-title":"Nat. Commun."},{"key":"625_CR149","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/annrheumdis-2013-204343","volume":"74","author":"AJ Clarke","year":"2015","unstructured":"Clarke, A. J. et al. Autophagy is activated in systemic lupus erythematosus and required for plasmablast development. Ann. Rheum. Dis. 74, 912\u2013920 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR150","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3390\/ijms20071792","volume":"20","author":"K Kemp","year":"2019","unstructured":"Kemp, K. & Poe, C. Stressed: the unfolded protein response in T cell development, activation, and function. Int. J. Mol. Sci. 20, 1792 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"625_CR151","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-14032-1","volume":"11","author":"BT Gaudette","year":"2020","unstructured":"Gaudette, B. T., Jones, D. D., Bortnick, A., Argon, Y. & Allman, D. mTORC1 coordinates an immediate unfolded protein response-related transcriptome in activated B cells preceding antibody secretion. Nat. Commun. 11, 723 (2020).","journal-title":"Nat. Commun."},{"key":"625_CR152","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","volume":"57","author":"RA Colbert","year":"2014","unstructured":"Colbert, R. A., Tran, T. M. & Layh-Schmitt, G. HLA-B27 misfolding and ankylosing spondylitis. Mol. Immunol. 57, 44\u201351 (2014).","journal-title":"Mol. Immunol."},{"key":"625_CR153","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","volume":"60","author":"ML DeLay","year":"2009","unstructured":"DeLay, M. L. et al. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 60, 2633\u20132643 (2009).","journal-title":"Arthritis Rheum."},{"key":"625_CR154","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/annrheumdis-2013-204170","volume":"73","author":"B Neerinckx","year":"2014","unstructured":"Neerinckx, B., Carter, S. & Lories, R. J. No evidence for a critical role of the unfolded protein response in synovium and blood of patients with ankylosing spondylitis. Ann. Rheum. Dis. 73, 629\u2013630 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR155","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/art.40414","volume":"70","author":"F Navid","year":"2018","unstructured":"Navid, F., Layh-Schmitt, G., Sikora, K. A., Cougnoux, A. & Colbert, R. A. The role of autophagy in the degradation of misfolded HLA-B27 heavy chains. Arthritis Rheumatol. 70, 746\u2013755 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR156","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2012-202925","volume":"73","author":"F Ciccia","year":"2014","unstructured":"Ciccia, F. et al. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Ann. Rheum. Dis. 73, 1566\u20131574 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR157","doi-asserted-by":"crossref","first-page":"17698","DOI":"10.1073\/pnas.1011736107","volume":"107","author":"JC Goodall","year":"2010","unstructured":"Goodall, J. C. et al. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc. Natl Acad. Sci. USA 107, 17698\u201317703 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"625_CR158","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.3389\/fimmu.2019.02821","volume":"10","author":"Y Jiao","year":"2019","unstructured":"Jiao, Y. & Sun, J. Bacterial manipulation of autophagic responses in infection and inflammation. Front. Immunol. 10, 2821 (2019).","journal-title":"Front. Immunol."},{"key":"625_CR159","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2013-204170","volume":"73","author":"B Neerinckx","year":"2014","unstructured":"Neerinckx, B., Carter, S. & Lories, R. IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis. Response to:\u2019Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation\u2019 by Ciccia et al. Ann. Rheum. Dis. 73, e68 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2014.12.031","volume":"42","author":"BH Duong","year":"2015","unstructured":"Duong, B. H. et al. A20 restricts ubiquitination of pro-interleukin-1\u03b2 protein complexes and suppresses NLRP3 inflammasome activity. Immunity 42, 55\u201367 (2015).","journal-title":"Immunity"},{"key":"625_CR161","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nature02794","volume":"430","author":"IE Wertz","year":"2004","unstructured":"Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694\u2013699 (2004).","journal-title":"Nature"},{"key":"625_CR162","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.it.2013.10.005","volume":"35","author":"L Catrysse","year":"2014","unstructured":"Catrysse, L., Vereecke, L., Beyaert, R. & van Loo, G. A20 in inflammation and autoimmunity. Trends Immunol. 35, 22\u201331 (2014).","journal-title":"Trends Immunol."},{"key":"625_CR163","doi-asserted-by":"crossref","first-page":"103914","DOI":"10.1016\/j.cellimm.2019.04.002","volume":"340","author":"BA Malynn","year":"2019","unstructured":"Malynn, B. A. & Ma, A. A20: a multifunctional tool for regulating immunity and preventing disease. Cell. Immunol. 340, 103914 (2019).","journal-title":"Cell. Immunol."},{"key":"625_CR164","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","volume":"289","author":"EG Lee","year":"2000","unstructured":"Lee, E. G. et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289, 2350\u20132354 (2000).","journal-title":"Science"},{"key":"625_CR165","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1038\/emboj.2012.240","volume":"31","author":"K Verhelst","year":"2012","unstructured":"Verhelst, K. et al. A20 inhibits LUBAC-mediated NF-\u03baB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J. 31, 3845\u20133855 (2012).","journal-title":"EMBO J."},{"key":"625_CR166","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ni.3172","volume":"16","author":"M Onizawa","year":"2015","unstructured":"Onizawa, M. et al. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat. Immunol. 16, 618\u2013627 (2015).","journal-title":"Nat. Immunol."},{"key":"625_CR167","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/eji.201444795","volume":"45","author":"NT Xuan","year":"2015","unstructured":"Xuan, N. T. et al. A20 expression in dendritic cells protects mice from LPS-induced mortality. Eur. J. Immunol. 45, 818\u2013828 (2015).","journal-title":"Eur. J. Immunol."},{"key":"625_CR168","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ni.2135","volume":"12","author":"GE Hammer","year":"2011","unstructured":"Hammer, G. E. et al. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat. Immunol. 12, 1184\u20131193 (2011).","journal-title":"Nat. Immunol."},{"key":"625_CR169","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.immuni.2011.05.013","volume":"35","author":"M Kool","year":"2011","unstructured":"Kool, M. et al. The ubiquitin-editing protein a20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 35, 82\u201396 (2011).","journal-title":"Immunity"},{"key":"625_CR170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/annrheumdis-2016-209454","volume":"76","author":"K De Wilde","year":"2017","unstructured":"De Wilde, K. et al. A20 inhibition of STAT1 expression in myeloid cells: A novel endogenous regulatory mechanism preventing development of enthesitis. Ann. Rheum. Dis. 76, 585\u2013592 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR171","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ng.874","volume":"43","author":"M Matmati","year":"2011","unstructured":"Matmati, M. et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat. Genet. 43, 908\u2013912 (2011).","journal-title":"Nat. Genet."},{"key":"625_CR172","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fimmu.2018.00104","volume":"9","author":"T Das","year":"2018","unstructured":"Das, T., Chen, Z., Hendriks, R. W. & Kool, M. A20\/tumor necrosis factor \u03b1-induced protein 3 in immune cells controls development of autoinflammation and autoimmunity: Lessons from mouse models. Front. Immunol. 9, 104 (2018).","journal-title":"Front. Immunol."},{"key":"625_CR173","doi-asserted-by":"crossref","first-page":"775","DOI":"10.15252\/embr.201338305","volume":"15","author":"A De","year":"2014","unstructured":"De, A., Dainichi, T., Rathinam, C. V. & Ghosh, S. The deubiquitinase activity of A20 is dispensable for NF-\u03baB signaling. EMBO Rep. 15, 775\u2013783 (2014).","journal-title":"EMBO Rep."},{"key":"625_CR174","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature16165","volume":"528","author":"IE Wertz","year":"2015","unstructured":"Wertz, I. E. et al. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 528, 370\u2013375 (2015).","journal-title":"Nature"},{"key":"625_CR175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41590-020-0621-9","volume":"21","author":"A Martens","year":"2020","unstructured":"Martens, A. et al. Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities. Nat. Immunol. 21, 381\u2013387 (2020).","journal-title":"Nat. Immunol."},{"key":"625_CR176","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41590-020-0634-4","volume":"21","author":"B Razani","year":"2020","unstructured":"Razani, B. et al. Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation. Nat. Immunol. 21, 422\u2013433 (2020).","journal-title":"Nat. Immunol."},{"key":"625_CR177","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.it.2020.03.001","volume":"41","author":"D Priem","year":"2020","unstructured":"Priem, D., van Loo, G. & Bertrand, M. J. M. A20 and cell death-driven inflammation. Trends Immunol. 41, 421\u2013435 (2020).","journal-title":"Trends Immunol."},{"key":"625_CR178","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.4049\/jimmunol.1400499","volume":"192","author":"SB Berger","year":"2014","unstructured":"Berger, S. B. et al. Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J. Immunol. 192, 5476\u20135480 (2014).","journal-title":"J. Immunol."},{"key":"625_CR179","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-018-0064-8","volume":"557","author":"N Peltzer","year":"2018","unstructured":"Peltzer, N. et al. LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis. Nature 557, 112\u2013117 (2018).","journal-title":"Nature"},{"key":"625_CR180","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809324","volume":"11","author":"RB Damgaard","year":"2019","unstructured":"Damgaard, R. B. et al. OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death. EMBO Mol. Med. 11, e9324 (2019).","journal-title":"EMBO Mol. Med."},{"key":"625_CR181","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.2457","volume":"13","author":"B Boisson","year":"2012","unstructured":"Boisson, B. et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat. Immunol. 13, 1178\u20131186 (2012).","journal-title":"Nat. Immunol."},{"key":"625_CR182","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.20141130","volume":"212","author":"B Boisson","year":"2015","unstructured":"Boisson, B. et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J. Exp. Med. 212, 939\u2013951 (2015).","journal-title":"J. Exp. Med."},{"key":"625_CR183","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","volume":"48","author":"Q Zhou","year":"2015","unstructured":"Zhou, Q. et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat. Genet. 48, 67\u201373 (2015).","journal-title":"Nat. Genet."},{"key":"625_CR184","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000740","volume":"4","author":"K Rajam\u00e4ki","year":"2018","unstructured":"Rajam\u00e4ki, K. et al. Haploinsufficiency of A20 impairs protein-protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation. RMD Open 4, e000740 (2018).","journal-title":"RMD Open"},{"key":"625_CR185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clim.2018.03.009","volume":"191","author":"C Franco-Jarava","year":"2018","unstructured":"Franco-Jarava, C. et al. TNFAIP3 haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13\u2009Mb on chromosome 6. Clin. Immunol. 191, 44\u201351 (2018).","journal-title":"Clin. Immunol."},{"key":"625_CR186","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3389\/fimmu.2017.00860","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Genetic and functional associations with decreased anti-inflammatory tumor necrosis factor alpha induced protein 3 in macrophages from subjects with axial spondyloarthritis. Front. Immunol. 8, 860 (2017).","journal-title":"Front. Immunol."},{"key":"625_CR187","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajhg.2014.12.024","volume":"96","author":"MJ Lewis","year":"2015","unstructured":"Lewis, M. J. et al. UBE2L3 polymorphism amplifies NF-\u03baB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am. J. Hum. Genet. 96, 221\u2013234 (2015).","journal-title":"J. Hum. Genet."},{"key":"625_CR188","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/eji.201041313","volume":"41","author":"N H\u00f6velmeyer","year":"2011","unstructured":"H\u00f6velmeyer, N. et al. A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur. J. Immunol. 41, 595\u2013601 (2011).","journal-title":"Eur. J. Immunol."},{"key":"625_CR189","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/intimm\/dxh364","volume":"18","author":"MA Blanco-Gelaz","year":"2006","unstructured":"Blanco-Gelaz, M. A. et al. The amino acid at position 97 is involved in folding and surface expression of HLA-B27. Int. Immunol. 18, 211\u2013220 (2006).","journal-title":"Int. Immunol."},{"key":"625_CR190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0002-9343(88)90385-3","volume":"85","author":"PL Schwimmbeck","year":"1988","unstructured":"Schwimmbeck, P. L. & Oldstone, M. B. A. Molecular mimicry between human leukocyte antigen B27 and klebsiella. Consequences for spondyloarthropathies. Am. J. Med. 85, 51\u201353 (1988).","journal-title":"Am. J. Med."},{"key":"625_CR191","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/art.24599","volume":"60","author":"JD Taurog","year":"2009","unstructured":"Taurog, J. D. et al. Spondylarthritis in HLA-B27\/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis Rheum. 60, 1977\u20131984 (2009).","journal-title":"Arthritis Rheum."},{"key":"625_CR192","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi, N. et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426, 454\u2013460 (2003).","journal-title":"Nature"},{"key":"625_CR193","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.38638","volume":"66","author":"H Benham","year":"2014","unstructured":"Benham, H. et al. Interleukin-23 mediates the intestinal response to microbial \u03b2-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol. 66, 1755\u20131767 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR194","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.39041","volume":"67","author":"AC Baillet","year":"2015","unstructured":"Baillet, A. C. et al. High Chlamydia burden promotes tumor necrosis factor-dependent reactive arthritis in SKG mice. Arthritis Rheumatol. 67, 1535\u20131547 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR195","doi-asserted-by":"crossref","first-page":"R521","DOI":"10.1186\/ar1221","volume":"6","author":"H Appel","year":"2004","unstructured":"Appel, H. et al. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis. Arthritis Res. Ther. 6, R521\u2013R534 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"625_CR196","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0140-6736(93)91760-J","volume":"342","author":"E Hermann","year":"1993","unstructured":"Hermann, E., Yu, D. T., Meyer zum B\u00fcschenfelde, K. H. & Fleischer, B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342, 646\u2013650 (1993).","journal-title":"Lancet"},{"key":"625_CR197","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.20948","volume":"52","author":"P Atagunduz","year":"2005","unstructured":"Atagunduz, P. et al. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis. Arthritis Rheum. 52, 892\u2013901 (2005).","journal-title":"Arthritis Rheum."},{"key":"625_CR198","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.4049\/jimmunol.167.8.4738","volume":"167","author":"W Kuon","year":"2001","unstructured":"Kuon, W. et al. Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases. J. Immunol. 167, 4738\u20134746 (2001).","journal-title":"J. Immunol."},{"key":"625_CR199","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI9295","volume":"106","author":"MT Fiorillo","year":"2000","unstructured":"Fiorillo, M. T., Maragno, M., Butler, R., Dupuis, M. L. & Sorrentino, R. CD8+ T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J. Clin. Invest. 106, 47\u201353 (2000).","journal-title":"J. Clin. Invest."},{"key":"625_CR200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4419-0298-6_19","volume":"649","author":"MT Fiorillo","year":"2009","unstructured":"Fiorillo, M. T. & Sorrentino, R. T-cell responses against viral and self-epitopes and HLA-B27 subtypes differentially associated with ankylosing spondylitis. Adv. Exp. Med. Biol. 649, 255\u2013262 (2009).","journal-title":"Adv. Exp. Med. Biol."},{"key":"625_CR201","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/art.41129","volume":"72","author":"E Gracey","year":"2019","unstructured":"Gracey, E. et al. Altered cytotoxicity profile of CD8+ T cells in ankylosing spondylitis. Arthritis Rheumatol. 72, 428\u2013434 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR202","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2008.088120","volume":"68","author":"L Zhang","year":"2009","unstructured":"Zhang, L., Jarvis, L. B. & Baek, H.-J. & Hill Gaston, J. S. Regulatory IL4+CD8+ T cells in patients with ankylosing spondylitis and healthy controls. Ann. Rheum. Dis. 68, 1345\u20131351 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR203","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/art.41252","volume":"72","author":"AL Hanson","year":"2020","unstructured":"Hanson, A. L. et al. T-cell receptor immunosequencing reveals altered repertoire diversity and disease-associated clonal expansions in ankylosing spondylitis patients. Arthritis Rheumatol. 72, 1289\u20131302 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"625_CR204","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2019-215349","volume":"78","author":"Z Qaiyum","year":"2019","unstructured":"Qaiyum, Z., Gracey, E., Yao, Y. C. & Inman, R. D. Integrin and transcriptomic profiles identify a distinctive synovial CD8+ T cell subpopulation in spondyloarthritis. Ann. Rheum. Dis. 78, 1566\u20131575 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR205","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216456","author":"G Guggino","year":"2019","unstructured":"Guggino, G., Rizzo, A., Mauro, D., Macaluso, F. & Ciccia, F. Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients. Ann. Rheum. Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216456 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR206","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","volume":"7","author":"W Zhu","year":"2019","unstructured":"Zhu, W. et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res. 7, 22 (2019).","journal-title":"Bone Res."},{"key":"625_CR207","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3899\/jrheum.110862","volume":"39","author":"L Lim\u00f3n-Camacho","year":"2012","unstructured":"Lim\u00f3n-Camacho, L. et al. In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis. J. Rheumatol. 39, 830\u2013835 (2012).","journal-title":"J. Rheumatol."},{"key":"625_CR208","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3389\/fimmu.2018.00885","volume":"9","author":"A Reinhardt","year":"2018","unstructured":"Reinhardt, A. & Prinz, I. Whodunit? The contribution of interleukin (IL)-17\/IL-22-producing \u03b3\u03b4 T cells, \u03b1\u03b2 T cells, and innate lymphoid cells to the pathogenesis of spondyloarthritis. Front. Immunol. 9, 885 (2018).","journal-title":"Front. Immunol."},{"key":"625_CR209","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.lfs.2013.09.003","volume":"93","author":"X-Y Niu","year":"2013","unstructured":"Niu, X.-Y. et al. Peripheral B-cell activation and exhaustion markers in patients with ankylosing spondylitis. Life Sci. 93, 687\u2013692 (2013).","journal-title":"Life Sci."},{"key":"625_CR210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1089\/dna.2015.3046","volume":"35","author":"M Chen","year":"2016","unstructured":"Chen, M. et al. Defective function of CD24(+)CD38(+) regulatory B cells in ankylosing spondylitis. DNA Cell Biol. 35, 88\u201395 (2016).","journal-title":"DNA Cell Biol."},{"key":"625_CR211","volume":"12","author":"MB Bautista-Caro","year":"2017","unstructured":"Bautista-Caro, M. B. et al. Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with ankylosing spondylitis (AS) na\u00efve for biological agents. PLoS ONE 12, e0180726 (2017).","journal-title":"PLoS ONE"},{"key":"625_CR212","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.27383","volume":"62","author":"IH Song","year":"2010","unstructured":"Song, I. H. et al. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. Arthritis Rheum. 62, 1290\u20131297 (2010).","journal-title":"Arthritis Rheum."},{"key":"625_CR213","doi-asserted-by":"crossref","first-page":"316421","DOI":"10.1155\/2015\/316421","volume":"2015","author":"X Feng","year":"2015","unstructured":"Feng, X., Xu, X., Wang, Y., Zheng, Z. & Lin, G. Ectopic germinal centers and IgG4-producing plasmacytes observed in synovia of HLA-B27+ ankylosing spondylitis patients with advanced hip involvement. Int. J. Rheumatol. 2015, 316421 (2015).","journal-title":"Int. J. Rheumatol."},{"key":"625_CR214","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/ar297","volume":"3","author":"J Voswinkel","year":"2001","unstructured":"Voswinkel, J., Weisgerber, K., Pfreundschuh, M. & Gause, A. B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection. Arthritis Res. 3, 189\u2013195 (2001).","journal-title":"Arthritis Res."},{"key":"625_CR215","doi-asserted-by":"crossref","first-page":"M9.00384","DOI":"10.1074\/mcp.M9.00384","volume":"11","author":"C Wright","year":"2012","unstructured":"Wright, C. et al. Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol. Cell. Proteom. 11, M9.00384 (2012).","journal-title":"Mol. Cell. Proteom."},{"key":"625_CR216","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/annrheumdis-2012-202208","volume":"73","author":"NT Baerlecken","year":"2014","unstructured":"Baerlecken, N. T. et al. Autoantibodies against CD74 in spondyloarthritis. Ann. Rheum. Dis. 73, 1211\u20131214 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR217","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/annrheumdis-2012-202177","volume":"73","author":"X Baraliakos","year":"2014","unstructured":"Baraliakos, X., Baerlecken, N., Witte, T., Heldmann, F. & Braun, J. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis. Ann. Rheum. Dis. 73, 1079\u20131082 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR218","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13075-018-1535-x","volume":"20","author":"JJ de Winter","year":"2018","unstructured":"de Winter, J. J. et al. Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort. Arthritis Res. Ther. 20, 38 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"625_CR219","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/annrheumdis-2013-203630","volume":"73","author":"FWL Tsui","year":"2013","unstructured":"Tsui, F. W. L., Tsui, H. W., Las Heras, F., Pritzker, K. P. H. & Inman, R. D. Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis. Ann. Rheum. Dis. 73, 1873\u20131879 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR220","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/art.24888","volume":"60","author":"H Appel","year":"2009","unstructured":"Appel, H. et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum. 60, 3257\u20133262 (2009).","journal-title":"Arthritis Rheum."},{"key":"625_CR221","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI23738","volume":"115","author":"RJU Lories","year":"2005","unstructured":"Lories, R. J. U., Derese, I. & Luyten, F. P. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J. Clin. Invest. 115, 1571\u20131579 (2005).","journal-title":"J. Clin. Invest."},{"key":"625_CR222","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3899\/jrheum.170833","volume":"45","author":"MM Luchetti","year":"2018","unstructured":"Luchetti, M. M. et al. Sclerostin and antisclerostin antibody serum levels predict the presence of axial spondyloarthritis in patients with inflammatory bowel disease. J. Rheumatol. 45, 630\u2013637 (2018).","journal-title":"J. Rheumatol."},{"key":"625_CR223","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13075-019-2018-4","volume":"21","author":"E Klingberg","year":"2019","unstructured":"Klingberg, E. et al. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin. Arthritis Res. Ther. 21, 248 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"625_CR224","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/cmi.2015.70","volume":"13","author":"X Ma","year":"2016","unstructured":"Ma, X., Aoki, T. & Narumiya, S. Prostaglandin E2-EP4 signaling persistently amplifies CD40-mediated induction of IL-23 p19 expression through canonical and non-canonical NF-\u03baB pathways. Cell. Mol. Immunol. 13, 240\u2013250 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"625_CR225","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jor.20962","volume":"28","author":"J Zhang","year":"2010","unstructured":"Zhang, J. & Wang, J. H.-C. Production of PGE(2) increases in tendons subjected to repetitive mechanical loading and induces differentiation of tendon stem cells into non-tenocytes. J. Orthop. Res. 28, 198\u2013203 (2010).","journal-title":"J. Orthop. Res."},{"key":"625_CR226","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/annrheumdis-2013-204835","volume":"74","author":"A Cortes","year":"2015","unstructured":"Cortes, A. et al. Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis. Ann. Rheum. Dis. 74, 1387\u20131393 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR227","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/acr.23097","volume":"69","author":"F Maas","year":"2017","unstructured":"Maas, F. et al. Reduction in spinal radiographic progression in ankylosing spondylitis patients receiving prolonged treatment with tumor necrosis factor inhibitors. Arthritis Care Res. 69, 1011\u20131019 (2017).","journal-title":"Arthritis Care Res."},{"key":"625_CR228","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/annrheumdis-2017-212377","volume":"77","author":"D van der Heijde","year":"2018","unstructured":"van der Heijde, D. et al. Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial. Ann. Rheum. Dis. 77, 699\u2013705 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"625_CR229","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.semarthrit.2020.07.009","volume":"50","author":"J-Y Jung","year":"2020","unstructured":"Jung, J.-Y., Kim, M.-Y., Hong, Y. S., Park, S.-H. & Kang, K. Y. Trabecular bone loss contributes to radiographic spinal progression in patients with axial spondyloarthritis. Semin. Arthritis Rheum. 50, 827\u2013833 (2020).","journal-title":"Semin. Arthritis Rheum."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41584-021-00625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-021-00625-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-021-00625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T19:22:01Z","timestamp":1699125721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-021-00625-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":229,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1038\/s41584-021-00625-y","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"23 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}